Ken Fisher's AGIO Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 870,145 shares of Agios Pharmaceuticals, Inc. (AGIO) worth $34.93 M, representing 0.01% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in AGIO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 145,416 shares. Largest reduction occurred in Q4 2023, reducing 105,898 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Agios Pharmaceuticals (AGIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Agios Pharmaceuticals (AGIO) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2022 | +839,390 | New Buy | 839,390 | $28.28 |
| Q4 2022 | +37,563 | Add 4.48% | 876,953 | $28.08 |
| Q1 2023 | -26,521 | Reduce 3.02% | 850,432 | $22.97 |
| Q2 2023 | +20,667 | Add 2.43% | 871,099 | $28.32 |
| Q3 2023 | -53,680 | Reduce 6.16% | 817,419 | $24.75 |
| Q4 2023 | -105,898 | Reduce 12.96% | 711,521 | $22.27 |
| Q1 2024 | -4,179 | Reduce 0.59% | 707,342 | $29.24 |
| Q2 2024 | +2,570 | Add 0.36% | 709,912 | $43.12 |
| Q3 2024 | +145,416 | Add 20.48% | 855,328 | $44.43 |
| Q4 2024 | +105,333 | Add 12.31% | 960,661 | $32.86 |
| Q1 2025 | -1,322 | Reduce 0.14% | 959,339 | $29.30 |
| Q2 2025 | -81,799 | Reduce 8.53% | 877,540 | $33.26 |
| Q3 2025 | -7,395 | Reduce 0.84% | 870,145 | $40.14 |
Ken Fisher's Agios Pharmaceuticals Investment FAQs
Ken Fisher first purchased Agios Pharmaceuticals, Inc. (AGIO) in Q3 2022, acquiring 839,390 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Agios Pharmaceuticals, Inc. (AGIO) for 13 quarters since Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to Agios Pharmaceuticals, Inc. (AGIO) was in Q3 2022, adding 839,390 shares worth $23.74 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 870,145 shares of Agios Pharmaceuticals, Inc. (AGIO), valued at approximately $34.93 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Agios Pharmaceuticals, Inc. (AGIO) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in Agios Pharmaceuticals, Inc. (AGIO) was 960,661 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.